This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

The Law Offices Of Nicholas Koluncich III, LLC, Based In Albuquerque, New Mexico, Announces An Investigation Into The Sale Of Sun Healthcare Group Inc. (SUNH)

The Law Offices of Nicholas Koluncich III, LLC is investigating the possibility of filing a claim or claims against the board of directors of Sun Healthcare Group Inc. ("Sun") ( SUNH) for the facts and circumstances surrounding the proposed acquisition of Sun by Genesis Healthcare ("Genesis").

On June 20, 2012, Sun filed an 8-K with the Securities and Exchange Commission informing that Sun had entered into a definitive agreement to sell itself to Genesis for $8.50 in cash per share, resulting in a transaction value of approximately $275 million net of cash and debt acquired. Current Sun Shareholders would retain no interest in Sun pursuant to the terms of this deal. That 8-K can be found here:

Shareholders and/or former employees are encouraged to contact us at the contact information below. Here, our investigation focuses on whether or not the members of Sun’s Board of Directors have or will continue to comply with their fiduciary and legal duties to sell the company pursuant to a fair sales process that will maximize shareholder value and in a manner that affirmatively discloses all material facts concerning the timing and terms of this going private transaction.

If you own Sun stock, have information about this company or would like a candid explanation of your rights, please contact:

The Law Offices of Nicholas Koluncich III, LLC
6501 Americas Parkway NE
One Park Square – Suite 820
Albuquerque, NM 87110
FAX 505-881-4288

There is never any charge for an initial consultation.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs